LPL Financial
GTHX

LPL Financial’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

LPL Financial’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,590
Closed -$157K – 4591
2022
Q3 		$157K Buy
12,590
+2,500
+25% +$28.6K ﹤0.01% 4012
2022
Q2 		$50K Hold
10,090
– – ﹤0.01% 4236
2022
Q1 		$77K Sell
10,090
-453
-4% -$4.3K ﹤0.01% 4015
2021
Q4 		$108K Sell
10,543
-315
-3% -$4.01K ﹤0.01% 4125
2021
Q3 		$146K Buy
10,858
+553
+5% +$9.01K ﹤0.01% 4063
2021
Q2 		$226K Buy
+10,305
New +$229K ﹤0.01% 3818
2021
Q1 		– Sell
-11,190
Closed -$201K – 4158
2020
Q4 		$201K Sell
11,190
-18,710
-63% -$280K ﹤0.01% 3526
2020
Q3 		$345K Buy
+29,900
New +$494K ﹤0.01% 2799

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial's GTHX Position: Q4 2022 in Review

LPL Financial sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2022, closing a stake of 12,590 shares — an estimated $157K sold.

LPL Financial first reported a position in GTHX in Q3 2020 and held it in 8 quarters. The position peaked at $345K in Q3 2020. 116 funds tracked by Wall St. Rank hold GTHX as of Q4 2022.

  • LPL Financial reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • LPL Financial sold 12,590 G1 Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $157K.
  • LPL Financial first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • LPL Financial's G1 Therapeutics, Inc. Common Stock position peaked at $345K in Q3 2020.
  • 116 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2022.

Based on LPL Financial's 13F filing for Q4 2022, filed 7 Feb 2023.